Skin biomarkers predict development of atopic dermatitis in infancy

Maria Rasmussen Rinnov1, Anne-Sofie Halling1,2, Trine Gerner1

  • 1Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

Allergy
|September 16, 2022
PubMed

Insights

Infant lipid alterations, including lower phytosphingosine, predict atopic dermatitis (AD) risk. Specific sphingoid base chain lengths and higher TARC/CCL17 also indicate future AD development.

Area of Science:

  • Dermatology
  • Biochemistry
  • Pediatrics

Background:

  • Pediatric atopic dermatitis (AD) lacks predictive biomarkers for early onset.
  • Understanding early skin barrier differences is crucial for predicting AD.

Purpose of the Study:

  • To identify early biomarkers predicting the onset of pediatric atopic dermatitis (AD).
  • To investigate skin barrier components in infants before AD manifestation.

Main Methods:

  • Analysis of tape strips from infants at 2 months of age.
  • Measurement of Natural moisturizing factor (NMF), corneocyte surface, cytokines, free sphingoid bases (SBs), and ceramides.
  • Utilized liquid chromatography, atomic force microscopy, and mass spectrometry.

Main Results:

  • Significantly lower phytosphingosine ([P]) levels observed in infants who developed AD (240 pmol/mg vs. 540 pmol/mg).
  • Differences noted in sphingoid base chain lengths (C17, C18, C20) between groups.
  • Phytosphingosine achieved 75.6% prediction accuracy; a lipid ratio combination reached 89.4%.

Conclusions:

  • Altered lipid levels and sphingoid base chain lengths in infants are associated with later AD development.
  • Elevated TARC/CCL17 levels were also observed in infants who developed AD.
  • These findings offer potential biomarkers for predicting pediatric atopic dermatitis.
Abstract

Related Concept Videos